发明名称 COMBINATIONS COMPRISING BCR-ABL/C-KIT/PDGF-R TK INHIBITORS FOR TREATING CANCER
摘要 <p>The invention relates to a combination comprising a Bcr-Abl, c-Kit and PDGF-R tyrosine kinase inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.</p>
申请公布号 KR20140020367(A) 申请公布日期 2014.02.18
申请号 KR20147002749 申请日期 2007.04.04
申请人 NOVARTIS AG 发明人 BURKE GREGORY PETER;LINNARTZ RONALD RICHARD;MANLEY PAUL W.;VERSACE RICHARD WILLIAM
分类号 A61K31/454;A61K31/4709;A61K31/473;A61P35/04 主分类号 A61K31/454
代理机构 代理人
主权项
地址